Skip to content

Groovy.Bio: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Groovy.Bio

BE 0776.937.633
NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparations
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€297,520
2024 · -€343,512+€45,992
Equity
€544,484
2024 · €327,004+€217,480
Cash
€694,335
2024 · €341,481+€352,854
Balance sheet total
€744,069
2024 · €363,086+€380,983

Largest movements

2024 to 2025
Assets
  • Cash +€352,854

    up €352,854 (+103%), from €341,481 to €694,335

    mainly Contributions, distributions and other (+€515,000) and Depreciation (+€276,613)

  • Deferred charges and accrued income +€10,740

    up €10,740 (+1,081%), from €994 to €11,734

  • Receivables after one year +€9,336

    up €9,336 (+74.5%), from €12,531 to €21,867

  • Receivables within one year +€8,054

    up €8,054 (+99.7%), from €8,078 to €16,132

    of which Other amounts receivable: +€11,630

Equity and liabilities
  • Contributions +€142,004

    up €142,004 (+20.3%), from €700,000 to €842,004

  • Accrued charges and deferred income +€91,630

    new in 2025: €91,630

  • Trade debts +€76,710

    up €76,710 (+266%), from €28,892 to €105,602

  • Profit (loss) carried forward +€75,475

    up €75,475 (+20.2%), from -€372,996 to -€297,520

Income statement
  • Depreciation -€46,780

    down €46,780 (-14.5%), from €323,393 to €276,613

  • Gross operating margin +€41,934

    up €41,934 (+70.3%), from -€59,655 to -€17,721

  • Financial income -€27,950

    down €27,950 (-100%), from €27,950 to €0

    of which Financial income: -€27,950

  • Staff costs +€11,537

    new in 2025: €11,537

  • Taxes +€3,196

    up €3,196 (+25.5%), from -€12,531 to -€9,336

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€343,512
Gross operating margin +€41,934
Staff costs -€11,537
Depreciation +€46,780
Other operating charges -€14
Financial income -€27,950
Financial charges -€25
Taxes -€3,196
Result 2025 -€297,520
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€114,467
Investment -€276,612
Financing +€515,000
Cash 2024 €341,481
Net result for the year -€297,520
Depreciation +€276,613
Receivables after one year -€9,336
Receivables within one year -€8,054
Deferred charges and accrued income -€10,740
Trade debts +€76,710
Tax, wage and social debts -€4,837
Accrued charges and deferred income +€91,630
Investment in fixed assets (net) -€276,612
Contributions, distributions and other +€515,000
Cash 2025 €694,335
brings cash intakes cash out
Every line side by side 38 lines
Line Code 2024 2025 Change %
Total assets 20/58 €363,086 €744,069 +€380,983 +105%
Fixed assets 21/28 €2 €1 -€1 -50.0%
Financial fixed assets 28 €2 €1 -€1 -50.0%
Current assets 29/58 €363,084 €744,068 +€380,984 +105%
Amounts receivable after more than one year 29 €12,531 €21,867 +€9,336 +74.5%
Other amounts receivable 291 €12,531 €21,867 +€9,336 +74.5%
Amounts receivable within one year 40/41 €8,078 €16,132 +€8,054 +99.7%
Trade receivables 40 €8,078 €4,503 -€3,576 -44.3%
Other amounts receivable 41 €0 €11,630 +€11,630
Cash at bank and in hand 54/58 €341,481 €694,335 +€352,854 +103%
Deferred charges and accrued income 490/1 €994 €11,734 +€10,740 +1,081%
Total equity and liabilities 10/49 €363,086 €744,069 +€380,983 +105%
Equity 10/15 €327,004 €544,484 +€217,480 +66.5%
Contributions 10/11 €700,000 €842,004 +€142,004 +20.3%
Profit (loss) carried forward 14 -€372,996 -€297,520 +€75,475 +20.2%
Amounts payable 17/49 €36,082 €199,586 +€163,503 +453%
Amounts payable within one year 42/48 €36,082 €107,955 +€71,873 +199%
Trade debts 44 €28,892 €105,602 +€76,710 +266%
Suppliers 440/4 €28,892 €105,602 +€76,710 +266%
Taxes, remuneration and social security 45 €7,190 €2,353 -€4,837 -67.3%
Taxes 450/3 €7,190 €200 -€6,990 -97.2%
Remuneration and social security 454/9 - €2,153 +€2,153
Accrued charges and deferred income 492/3 - €91,630 +€91,630
Remuneration, social security and pensions 62 - €11,537 +€11,537
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €323,393 €276,613 -€46,780 -14.5%
Other operating charges 640/8 €505 €520 +€14 +2.8%
Gross operating margin 9900 -€59,655 -€17,721 +€41,934 +70.3%
Operating profit (loss) 9901 -€383,554 -€306,391 +€77,163 +20.1%
Financial income 75/76B €27,950 €0 -€27,950 -100%
Recurring financial income 75 €27,950 €0 -€27,950 -100%
Non-recurring financial income 76B €0 - =
Financial charges 65/66B €439 €465 +€25 +5.8%
Recurring financial charges 65 €439 €465 +€25 +5.8%
Non-recurring financial charges 66B €0 - =
Profit (loss) for the period before taxes 9903 -€356,044 -€306,856 +€49,188 +13.8%
Income taxes 67/77 -€12,531 -€9,336 +€3,196 +25.5%
Profit (loss) for the period 9904 -€343,512 -€297,520 +€45,992 +13.4%
Profit (loss) for the period to be appropriated 9905 -€343,512 -€297,520 +€45,992 +13.4%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.